JNJ - JOHNSON & JOHNSON
227.5
-3.150 -1.385%
Share volume: 5,689,219
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$230.65
-3.15
-0.01%
View ratios
| Fiscal Date | 06-30-2024 | 09-29-2024 | 12-29-2024 | 03-30-2025 | 06-29-2025 | 09-28-2025 | 12-28-2025 | 03-29-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 07-25-2024 | 10-23-2024 | 02-13-2025 | 04-23-2025 | 07-24-2025 | 10-22-2025 | 02-11-2026 | 04-22-2026 | |
| Total revenue | 22.447 B | 22.471 B | 22.520 B | 21.893 B | 23.743 B | 23.993 B | 24.564 B | 24.062 B | |
| Cost of revenue | 6.869 B | 6.963 B | 7.128 B | 7.357 B | 7.628 B | 7.303 B | 7.968 B | 8.106 B | |
| Gross profit | 15.578 B | 15.508 B | 15.392 B | 14.536 B | 16.115 B | 16.690 B | 16.596 B | 15.956 B | |
| -0.45% | -0.75% | -5.56% | 10.86% | 3.57% | -0.56% | -3.86% | |||
| Operating expenses | 9.315 B | 10.430 B | 11.768 B | 8.337 B | 9.405 B | 9.594 B | 11.086 B | 9.597 B | |
| Selling general and admin | 5.681 B | 5.478 B | 6.453 B | 5.112 B | 5.889 B | 5.922 B | 6.753 B | 6.034 B | |
| Research and development | 3.634 B | 4.952 B | 5.315 B | 3.225 B | 3.516 B | 3.672 B | 4.333 B | 3.563 B | |
| Total expenses | 9.302 B | 10.471 B | 11.810 B | 8.354 B | 9.469 B | 9.657 B | 11.170 B | 9.629 B | |
| 12.57% | 12.79% | -29.26% | 13.35% | 1.99% | 15.67% | -13.80% | |||
| Operating income | 6.276 B | 5.037 B | 3.582 B | 6.182 B | 6.646 B | 7.033 B | 5.426 B | 6.327 B | |
| Ebit | 5.623 B | 3.239 B | 3.743 B | 13.503 B | 6.539 B | 7.511 B | 4.943 B | 6.033 B | |
| Pretax income | 5.748 B | 3.338 B | 3.887 B | 13.631 B | 6.491 B | 7.493 B | 4.966 B | 5.990 B | |
| -41.93% | 16.45% | 250.68% | -52.38% | 15.44% | -33.72% | 20.62% | |||
| Income tax | 1.062 B | 644.000 M | 456.000 M | 2.632 B | 954.000 M | 2.341 B | -150.000 M | 755.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 4.686 B | 2.694 B | 3.431 B | 10.999 B | 5.537 B | 5.152 B | 5.116 B | 5.235 B | |
| -42.51% | 27.36% | 220.58% | -49.66% | -6.95% | -0.70% | 2.33% |